Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Nice Buy of 50,000 Shares @ .315

Question-In your proposed end-game scenario - What's to stop other prospective licensees from doing just what the T3 did-in effect keeping the N California venue alive by preempting TPL/Alliacense and filing suit first?

Share
New Message
Please login to post a reply